Richard J. Markham Joins Care Capital LLC
PRINCETON, N.J., Nov. 15 /PRNewswire/ -- Care Capital LLC, an investment firm focusing on later stage pharmaceutical and biotechnology enterprises, announced today that Richard J. Markham, former Vice Chair of the Management Board and Chief Operating Officer of Aventis, has joined the firm as a Partner.
Mr. Markham joins an impressive team of partners at Care Capital including Jan Leschly, former CEO of SmithKlineBeecham, Jerry Karabelas, former CEO of Worldwide Pharmaceuticals at Novartis AG, and David Ramsay, former Managing Director of the Rhone Group, LLC and Member of the Investment Committee of Morgan Stanley Capital Partners. With the addition of Mr. Markham, the Care Capital team will have over 100 years of scientific, development, commercialization and investment experience, making the company uniquely positioned to help growing companies to achieve their strategic goals.
Jan Leschly, Founding Partner of Care Capital, said, "We are thrilled that Dick has agreed to become our partner. He has had a long and illustrious career spanning several decades in the pharmaceutical industry in very senior positions. Pharmaceutical and biotechnology companies face a highly complex array of scientific, operational, regulatory, and management challenges. Dick's experience and knowledge will be invaluable in evaluating potential investments and assisting portfolio companies in developing and executing their strategic plans."
Mr. Markham said, "Having spent the last few years handling the day to day responsibilities of managing a large global pharmaceutical company, I'm excited by the prospect of being more hands on and getting back to what really makes a difference in the industry. Working with Care Capital I will be able to apply my years of experience to guiding our companies through the many challenges of taking a compound through development to commercialization."
Prior to joining Aventis, Mr. Markham served as President and Chief Operating Officer of Merck & Co., Inc. He was also responsible for Merck's European pharmaceutical business as Senior Vice President and also served as Vice President of Marketing for Merck's Sharp & Dohme Division. Mr. Markham has served as a Trustee of the Health Care Institute, as a Member of the Board of Directors for Pharmaceuticals Research and Manufacturers of America, and for Dade Behring, Inc. Mr. Markham is a graduate of the Purdue University School of Pharmacy and Pharmacal Sciences.
About Care Capital
Care Capital is a life sciences investment firm focused on drug development opportunities in pharmaceutical and biopharmaceutical companies. The firm is based in Princeton, NJ. For additional information visit http://www.carecapital.com/.
Press Contact: Rachel Spielman, Ruder Finn 212-583-2714Care Capital LLC
CONTACT: Rachel Spielman, Ruder Finn +1-212-583-2714, for Care CapitalLLC
Web site: http://www.carecapital.com/